NMN dose: what trial protocols have used

People searching for an NMN dose usually want a single number to follow. The honest answer is that there is no established dose for a food supplement with no licensed medical use, only a spread of amounts that trials happened to test. This post explains that distinction. It is editorial commentary and explicitly not a dosing instruction. We do not sell NMN, and dose questions belong with a healthcare professional.

Why there is no official NMN dose

A dose, in the medical sense, is a recommended amount tied to a licensed use and a body of evidence. NMN has neither. It is sold in the UK as a food supplement, not a licensed medicine, so there is no marketing authorisation, no approved indication, and therefore no official dose. The regulatory status post explains how that classification came about.

What exists instead is a set of amounts that researchers chose for individual trials. Those choices were made to test a hypothesis in a specific group of people, not to recommend a daily intake to the public. Reading a trial protocol as a personal instruction confuses a research design with medical guidance.

What trial protocols have used, as background

Across published human trials, the daily amounts of NMN tested have varied from study to study, with most trials running a few weeks to a few months. The reported outcomes have largely been biomarker shifts, such as changes in blood NAD+ markers, rather than clinically meaningful endpoints. Effect sizes have varied by population, with some studies in older or metabolically impaired groups showing larger shifts than studies in healthy younger adults.

We are deliberately not converting that into a recommended number. The point of describing the trial range at all is to give context for why supplement labels cluster where they do, and to show that the cheaper, lower-strength products often sit below what the studies used. The NMN label-reading post covers how to find the per-capsule figure so you can see where a given product falls.

Why more is not assumed to be better

It is tempting to read a dose range and assume the top of it is the target. The evidence does not support that assumption. Trials have not established a clean dose-response curve that justifies maximising intake, and higher amounts have not been shown to deliver proportionally better outcomes in humans. With no large long-term randomised trials, the safety of sustained higher intake is also not well characterised, a point the NMN side-effects post develops.

Where dose decisions actually belong

If you are considering NMN, the right place to settle a dose is a conversation with a healthcare professional, especially if you take any medication or manage a health condition. A clinician can weigh your circumstances in a way no published average can. That is not a disclaimer bolted on at the end: it is the genuine answer to the dose question for a food supplement.

For the wider context, the NMN sub-hub is the parent page, and the NMN supplement vs IV NAD+ comparison covers how the supplement route compares with the clinic routes on evidence and cost.